Yan Zhang

Dr. Yan Zhang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2011 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YZYinghua Zhu
Yinghua Zhu
FYFengyan Yu
Fengyan Yu
YJYu Jiao
Yu Jiao
JFJuan Feng
Juan Feng
WTWei Tang
Wei Tang
ESErwei Song
Erwei Song
Purpose: Tumor-initiating cells are resistant to chemotherapy, but how microRNAs play a role in regulating drug resistance of breast tumor–initiating cells (BT-IC) needs to be clarified.

25 February 2013 in Stem Cells
Verified
Journal Article
Open access
PDF file
HZHaixia Zhang
Haixia Zhang
HWHaotong Wu
Haotong Wu
JZJunheng Zheng
Junheng Zheng
PYPei Yu
Pei Yu
LXLixiao Xu
Lixiao Xu
YZYan Zhang
Yan Zhang
Human osteosarcoma harbors a small subpopulation of cancer stem cells (CSCs) that is believed to be associated with tumor metastasis, radioresistance/chemoresistance, local invasion, and poor clinical outcome. In this study, we found that transforming growth factor β1 (TGF-β1) signaling and a hypoxic environment dramatically induced self-renewal capacity in non-stem osteosarcoma cells, which in turn promoted chemoresistance, tumorigenicity, neovasculogenesis, and metastatic potential. Furthermore, blocking the TGF-β1 signaling pathway resulted in the inhibition of the dedifferentiation and clonogenicity of osteosarcoma cells, and the reduction of CSC self-renewal capacity and hypoxia-mediated dedifferentiation. These findings demonstrate that stem cells and non-stem cells exist in a dynamic equilibrium within the osteosarcoma cell population, and that CSCs may develop de novo from differentiated cancer cells. Hierarchical models of mammalian CSCs, therefore, should be considered to serve as bidirectional interconversion between the stem and non-stem cell components of the tumor.

15 April 2011 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
DSDahui Sun
Dahui Sun
XWXu Wang
Xu Wang
HZHaixia Zhang
Haixia Zhang
LDLijuan Deng
Lijuan Deng
YZYan Zhang
Yan Zhang

27 August 2014 in Journal of Oceanography
Verified
Journal Article
Closed access
PDF file
XCXiaoqing Cai
Xiaoqing Cai
YZYan Zhang
Yan Zhang

29 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TZTao Zeng
Tao Zeng
HGHongyi Gao
Hongyi Gao
PYPei Yu
Pei Yu
HHHeng He
Heng He
XOXiaoming Ouyang
Xiaoming Ouyang
YZYan Zhang
Yan Zhang
Kin17 is ubiquitously expressed at low levels in human tissue and participates in DNA replication, DNA repair and cell cycle control. Breast cancer cells are characterized by enabling replicative immortality and accumulated DNA damage. However, whether kin17 contributes to breast carcinogenesis remains unknown. In this study, we show for the first time that kin17 is an important molecule related to breast cancer. Our results show that kin17 expression was markedly increased in clinical breast tumors and was associated with tumor grade, Ki-67 expression, p53 mutation status and progesterone receptor expression, which were assessed in a clinicopathologic characteristics review. Knockdown of kin17 inhibited DNA replication and repair, blocked cell cycle progression and inhibited anchorage-independent growth, while increasing sensitivity to chemotherapy in breast cancer cells. Moreover, kin17 silencing decreased EGF-stimulated cell growth. Furthermore, overexpression of kin17 promoted DNA replication and cell proliferation in MCF-10A. Our findings indicate that up-regulation of kin17 is strongly associated with cellular proliferation, DNA replication, DNA damage response and breast cancer development. The increased level of kin17 was not only a consequence of immortalization but also associated with tumorigenesis. Therefore, kin17 could be a novel therapeutic target for inhibiting cell growth in breast cancer.

1 December 2017 in Biomaterials
Verified
Journal Article
Closed access
YMYanyan Miao
Yanyan Miao
HZHaixia Zhang
Haixia Zhang
YPYubin Pan
Yubin Pan
JRJian Ren
Jian Ren
MYMiaoman Ye
Miaoman Ye
YZYan Zhang
Yan Zhang